Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 25.26
+0.34 (1.36%)
At close: Mar 6, 2026
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 10.39 billion as of March 6, 2026. Its market cap has decreased by -3.16% in one year.
Market Cap
10.39B
Enterprise Value
5.33B
Revenue
1.39B
Ranking
n/a
PE Ratio
76.55
Stock Price
25.26
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 10.39B, a decrease of -68.82%. That is a compound annual growth rate of -23.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.39B | -1.94% |
| Dec 31, 2025 | 10.59B | -0.17% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
| Oct 28, 2021 | 33.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 11.66B |
| InventisBio | 11.42B |
| Hualan Biological Vaccine | 11.25B |
| Beijing Hotgen Biotech | 10.78B |
| Chengzhi | 10.45B |
| HitGen | 10.45B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.40B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.30B |